Affinity Investment Advisors’s Boston Scientific BSX Stock Holding History

Affinity Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-618,974	Closed	-$15.4M	–	174
2017 Q1	$15.4M	Sell	618,974 -44,887	-7%	-$1.09M	1.39%	25
2016 Q4	$14.4M	Sell	663,861 -137,403	-17%	-$3M	1.35%	27
2016 Q3	$19.1M	Sell	801,264 -298,809	-27%	-$7.13M	1.62%	13
2016 Q2	$25.7M	Buy	1,100,073 +47,305	+4%	+$1.02M	1.9%	6
2016 Q1	$19.8M	Sell	1,052,768 -1,432	-0.1%	-$25.2K	1.74%	12
2015 Q4	$19.4M	Buy	+1,054,200	New	+$18.9M	1.67%	15

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Affinity Investment Advisors's BSX Position: Q2 2017 in Review

Affinity Investment Advisors sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 618,974 shares — an estimated $15.4M sold.

Affinity Investment Advisors first reported a position in BSX in Q4 2015 and held it in 6 quarters. The position peaked at $25.7M in Q2 2016. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

Affinity Investment Advisors reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
Affinity Investment Advisors sold 618,974 Boston Scientific shares in Q2 2017, an estimated $15.4M.
Affinity Investment Advisors first reported a position in Boston Scientific in Q4 2015 and held it in 6 quarters.
Affinity Investment Advisors's Boston Scientific position peaked at $25.7M in Q2 2016.
558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Affinity Investment Advisors's 13F filing for Q2 2017, filed 25 Jul 2017.